Suven Life Sciences' Stock Faces Decline, Underperforms Sector and Sensex

Suven Life Sciences, a smallcap pharmaceutical company, has recently faced a decline in its stock price. On October 7th, 2024, the company's stock lost -7.05%, underperforming the sector by -4.52%. This has led to a 'Sell' call by MarketsMOJO.

The stock has been on a consecutive fall for the last 3 days, with a total decline of -7.11% during this period. On the same day, the stock touched an intraday low of Rs 134.35, a decrease of -5.25%. However, the stock's moving averages are still higher than its 100 day and 200 day averages, but lower than its 5 day, 20 day, and 50 day averages.

In comparison to the Sensex performance, Suven Life Sciences' 1 day performance is -7.12%, while the Sensex has only seen a decline of -0.25%. Similarly, the company's 1 month performance is -12.64%, while the Sensex has seen a slight increase of 0.37%.

Despite these recent declines, Suven Life Sciences remains a smallcap company in the pharmaceutical industry. As a fact-based article, it is important to note that this news is based on the company's stock performance and does not reflect any future potential or expert opinions. Investors are advised to do their own research and make informed decisions.